Angiogenesis: Principles and Importance in Cancer and Ischemic Heart Disease

08:15 – 09:30

Chairs: Jeffrey L. Evelhoch, Roderic I. Pettigrew and Robert M . Weisskoff

Educational Objectives

Upon completion of this session participants should be able to:

• Explain the basic principles of angiogenesis and its importance in cancer and ischemic heart disease.

• Describe the principles of anti-angiogenic therapy and its potential clinical utility in oncology.

• Explain the basis underlying MR methods used to assess the extent of angiogenesis in vivo.

• List examples of information which MR studies of tumors in vivo can provide regarding the angiogenic process.

• Describe the principles of angiogenic gene therapy and its potential clinical utility in ischemic heart disease.

08:15 139. Angiogenesis: Fundamental and Medical Applications, Judah Folkman, Harvard University Medical School, Boston, MA, USA.
08:40 140. MR Evaluation of Angiogenesis in Oncology, Michal Neeman, Weizmann Institute of Science, Rehovot, Israel.
09:05 141. Angiogenic Therapy in Ischemic Heart Disease, Stephen E. Epstein, Cardiovascular Research Foundation at Washington Hospital Center, Washington, D.C., USA.

Return to ISMRM program